Moving towards a cheap and easy way to monitor HIV/AIDS

Doctors regularly monitor the level of an immune cell in the blood called a CD4 cell in HIV-infected individuals, to decide when to start treatment and when to change medications. Unfortunately, the existing reliable CD4 counters are large and expensive pieces of equipment, and every actual count is not only expensive but also requires considerable expertise. These tools are therefore unsuitable for many low-income countries.

William Rodriguez and colleagues now report a new way of counting CD4 cells that is cheaper and easier than the current state-of-the-art technology. As they describe in the July issue of the international medical journal PLoS Medicine, their prototype performed well when tested on real-life samples, mostly from adult patients. Its reliability was as good as the existing counters in the range of counts where CD4 numbers are most critical to inform treatment decisions. A fully portable handheld model is now under development. After some modest training, such a tool should allow a variety of health care workers in remote areas to accurately analyze the CD4 status of HIV infected patients locally.

In an accompanying Perspective article, Zvi Bentwich (of Hebrew University in Jerusalem) argues that "the absence of tools to measure CD4 counts clearly jeopardizes the success of recently launched global campaigns to fight AIDS". While acknowledging that several issues remain to be resolved before the assay can become a widely used tool in resource-poor settings, Bentwich states "the authors of this study should be commended for addressing an extremely important issue and developing this novel approach for counting CD4 in patients with HIV."

http://www.plosmedicine.org

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows safety of kidney transplants among those with HIV infections